Bangladesh Pharma Market: 2013

According to the Bangladesh Pharmaceutical Index 2013(1^st Quarter) Total Market size of Bangladesh Pharma Market is Tk 9441 Crore (Local only, except import and export). As usual Sqaure Pharmaceutical Limited leading in front with the 18 % of share of total pharma market, though they are slightly behind from the National Market Growth of 8%. Novo Nordisk has the highest 27% growth in this market with only 8 Generics (Insulin based), UniMed UniHealth has the second highest (20%) and Healthcare Pharma (19%) has the third highest growth in the 1^st Quarter’2013.

Top 20 Generics of Bangladesh Pharma Market: 2011

Rank	Generic	Market Size (Cr)	Grw%	Position Change from last year	No. of Manufacturer
1	OMEPRAZOLE	482	26	▬	98
2	CEFIXIME	276	30	▲1	71
3	AZITHROMYCIN	245	20	▲1	62
4	RANITIDINE	245	14	▼2	95
5	PARACETAMOL	211	24	▲1	109
6	ESOMEPRAZOLE	211	67	▲4	45
7	CIPROFLOXACIN	203	9	▼2	118
8	CEFUROXIME	183	34	▼1	41
9	INSULIN HU	134	32	▲4	6
10	ZINC	134	16	▲2	301
11	PANTOPRAZOLE	133	41	▲5	40
12	CEFTRIAXONE	133	2	▼4	34
13	AMOXICILLIN	129	3	▼2	97
14	CEFRADINE	125	-2	▼5	80
15	LOSARTAN	123	33	▲2	59
16	AMLODIPINE	122	26	▼1	61
17	INSULIN H. iso	114	36	▲3	6
18	DICLOFENAC	112	14	▼4	107
19	ATORVASTATIN	112	38	▬	39
20	KETOROLAC	109	26	▼2	50